CLEXANE Side Effects

7022261-5 | Anaemia, Erosive Oesophagitis, Gastroduodenitis
on Sep 21, 2010 Male patient from ITALY , 92 years of age, was diagnosed with prophylaxis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, erosive oesophagitis, gastroduodenitis. Clexane dosage: . During the same period patient was treated with DELTACORTENE (View Deltacortene Review and Deltacortene Label ), LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ). Patient was hospitalized.

7022223-8 | Toxic Skin Eruption
Patient was taking Clexane (View Usage). Patient had the following side effects: toxic skin eruption on Sep 28, 2010 from CHINA Additional patient health information: Female patient , 54 years of age, weighting 114.6 lb, was diagnosed with thrombosis prophylaxis and. Clexane dosage: Dose:4000 Unit(s). During the same period patient was treated with ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), COZAAR (View Cozaar Review and Cozaar Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), BETALOC (View Betaloc Review and Betaloc Label ). Patient was hospitalized.

7020877-3 | Myocardial Ischaemia
Adverse event was reported on Jul 02, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with infection prophylaxis, rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: GREECE , 79 years of age, weighting 165.3 lb, After Clexane was administered, patient had the following side effects: myocardial ischaemia. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), ARAVA (View Arava Review and Arava Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), RIFADIN (View Rifadin Review and Rifadin Label ), PLAVIX (View Plavix Review and Plavix Label ), SALOSPIR (View Salospir Review and Salospir Label ). Patient was hospitalized.

7017946-0 | Pancreatitis Relapsing
on Sep 02, 2010 Male patient from GERMANY , 45 years of age, was diagnosed with thrombosis prophylaxis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis relapsing. Clexane dosage: . During the same period patient was treated with ILOMEDIN (View Ilomedin Review and Ilomedin Label ), BUDESONIDE/FORMOTEROL (View Budesonide/formoterol Review and Budesonide/formoterol Label ).


7017932-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Sep 21, 2010 Female patient from JAPAN , 56 years of age, weighting 90.83 lb, was diagnosed with prophylaxis, thrombosis prophylaxis, pain prophylaxis, anaemia and was treated with Clexane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Clexane dosage: . During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), HEPARIN CALCIUM (Dose:5000 Unit(s)) (View Heparin Calcium Review and Heparin Calcium Label ), PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), ATARAX (View Atarax Review and Atarax Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), FERROMIA (View Ferromia Review and Ferromia Label ).

7012447-8 | Diarrhoea, Loss Of Consciousness, Muscle Contractions Involuntary
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: diarrhoea, loss of consciousness, muscle contractions involuntary on Sep 15, 2010 from NETHERLANDS Additional patient health information: Male patient , 76 years of age, was diagnosed with prophylaxis and. Clexane dosage: . During the same period patient was treated with LACTULOSE (View Lactulose Review and Lactulose Label ), ACETAMINOPHEN (6 Times Per Days) (View Acetaminophen Review and Acetaminophen Label ), GLUCAGEN (View Glucagen Review and Glucagen Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ), DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ). Patient was hospitalized.

7004883-0 | Blood Pressure Increased
Adverse event was reported on Sep 09, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) . Location: GERMANY , 53 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased.

7004875-1 | Blood Pressure Decreased, Circulatory Collapse, Nausea, Tremor
on Sep 09, 2010 Female patient from GERMANY , 49 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Clexane (View Usage). Patient had the following side effects: blood pressure decreased, circulatory collapse, nausea (What is nausea?), tremor. Clexane dosage: . Patient was hospitalized.

6984909-0 | Embolism Arterial, Vascular Graft Occlusion
on Aug 31, 2010 Female patient from GERMANY , 68 years of age, was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: embolism arterial, vascular graft occlusion. Clexane dosage: . During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ).

6973003-0 | Atrial Thrombosis, Off Label Use
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: atrial thrombosis, off label use on Aug 31, 2010 from IRELAND Additional patient health information: Male patient , 44 years of age, . Clexane dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), BUMEX (View Bumex Review and Bumex Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6960195-2 | Anaemia, Haematocrit Decreased, Haemoglobin Decreased, Infection, Post Procedural Haematoma, Red Blood Cell Count Decreased
Adverse event was reported on Aug 20, 2010 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with bladder operation, hypertension, infection prophylaxis and. Location: JAPAN , 85 years of age, weighting 110.2 lb, Patient had the following side effects: anaemia, haematocrit decreased, haemoglobin decreased, infection (What is infection?), post procedural haematoma, red blood cell count decreased. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOL (View Pantol Review and Pantol Label ), GASTER (View Gaster Review and Gaster Label ), ZOSYN (View Zosyn Review and Zosyn Label ).

6955454-3 | Alanine Aminotransferase Abnormal, Aspartate Aminotransferase Abnormal, Hepatic Function Abnormal, Puncture Site Pain
on Aug 26, 2010 Female patient from JAPAN , 56 years of age, weighting 90.83 lb, was diagnosed with prophylaxis, thrombosis prophylaxis, pain prophylaxis, anaemia and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, hepatic function abnormal, puncture site pain. Clexane dosage: . During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), HEPARIN CALCIUM (Dose:5000 Unit(s)) (View Heparin Calcium Review and Heparin Calcium Label ), PENTAZOCINE LACTATE (View Pentazocine Lactate Review and Pentazocine Lactate Label ), ATARAX (View Atarax Review and Atarax Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), FERROMIA (View Ferromia Review and Ferromia Label ).

6955405-1 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased, Hepatic Function Abnormal
on Aug 19, 2010 Female patient from JAPAN , 60 years of age, weighting 117.3 lb, was diagnosed with abdominal operation, procedural pain, prophylaxis, infection prophylaxis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic enzyme increased, hepatic function abnormal. Clexane dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), LOXONIN (View Loxonin Review and Loxonin Label ), SELBEX (View Selbex Review and Selbex Label ), CEFMETAZON (View Cefmetazon Review and Cefmetazon Label ). Patient was hospitalized.

6955368-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Function Abnormal
Patient was taking Clexane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal on Aug 19, 2010 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 145.5 lb, was diagnosed with abdominal operation, prophylaxis and. Clexane dosage: . During the same period patient was treated with NSAID'S (View Nsaid's Review and Nsaid's Label ), CEFMETAZON (View Cefmetazon Review and Cefmetazon Label ), DAIKENTYUTO (View Daikentyuto Review and Daikentyuto Label ), LOXONIN (View Loxonin Review and Loxonin Label ), SELBEX (View Selbex Review and Selbex Label ). Patient was hospitalized.

6935864-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Aug 19, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with abdominal operation and. Location: JAPAN , 69 years of age, weighting 133.4 lb, After Clexane was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. During the same period patient was treated with PRORENAL (View Prorenal Review and Prorenal Label ), TENORMIN (View Tenormin Review and Tenormin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), HALCION (View Halcion Review and Halcion Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ). Patient was hospitalized.

6931876-1 | Eczema
on Aug 17, 2010 Female patient from SPAIN , 80 years of age, was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?). Clexane dosage: . During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.

6922867-5 | Eczema
on Aug 10, 2010 Female patient from SPAIN , 80 years of age, was treated with Clexane (View Usage). Patient had the following side effects: eczema (What is eczema?). Clexane dosage: . During the same period patient was treated with HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ). Patient was hospitalized.

6922862-6 | Cardiogenic Shock
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: cardiogenic shock on Aug 11, 2010 from MEXICO Additional patient health information: Female patient , 64 years of age, was diagnosed with acute myocardial infarction and. Clexane dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), AGRASTAT (View Agrastat Review and Agrastat Label ).

6914345-4 | Dermatitis Exfoliative
Adverse event was reported on Jul 29, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) . Location: ITALY , 90 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

6910610-5 | Foetal Growth Restriction
on Jul 29, 2010 Female patient from SWITZERLAND , 31 years of age, was treated with Clexane (View Usage). Patient had the following side effects: foetal growth restriction. Clexane dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LIQUEMINE (View Liquemine Review and Liquemine Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), CORONARY VASODILATORS (View Coronary Vasodilators Review and Coronary Vasodilators Label ).

6905628-2 | Disease Progression, Lung Cancer Metastatic, Pulmonary Haemorrhage
on Jul 30, 2010 Male patient from UNITED KINGDOM , 61 years of age, was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: disease progression, lung cancer metastatic, pulmonary haemorrhage. Clexane dosage: . During the same period patient was treated with DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ), CODEINE LINCTUS (View Codeine Linctus Review and Codeine Linctus Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6905607-5 | Haematoma, Infection, Intestinal Haemorrhage
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, infection (What is infection?), intestinal haemorrhage on Jul 26, 2010 from AUSTRALIA Additional patient health information: Female patient , 65 years of age, weighting 147.7 lb, . Clexane dosage: . Patient was hospitalized.

6866509-6 | Flank Pain, Thrombocytopenia, Vomiting
Adverse event was reported on Jul 14, 2010 by a Female patient taking Clexane (View Usage) (Dosage: Dose:1 Unit(s)) was diagnosed with extracorporeal circulation and. Location: ITALY , 86 years of age, Patient had the following side effects: flank pain, thrombocytopenia, vomiting. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LANOXIN (Dose:1 Unit(s)) (View Lanoxin Review and Lanoxin Label ), GARDENALE (Dose:1 Unit(s)) (View Gardenale Review and Gardenale Label ), LASIX (View Lasix Review and Lasix Label ), HUMULIN R (View Humulin R Review and Humulin R Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6863031-8 | Haematoma, Infection, Intestinal Haemorrhage
on Jul 13, 2010 Female patient from AUSTRALIA , 60 years of age, weighting 147.7 lb, was diagnosed with prophylaxis and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: haematoma, infection (What is infection?), intestinal haemorrhage. Clexane dosage: . Patient was hospitalized.

6860164-7 | Rash, Respiratory Failure
on Jul 08, 2010 Female patient from ITALY , 70 years of age, was diagnosed with phlebitis and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), respiratory failure. Clexane dosage: Dose:1 Unit(s).

6856083-2 | Disease Progression, Lung Cancer Metastatic, Pulmonary Haemorrhage
Patient was taking Clexane (View Usage). Patient had the following side effects: disease progression, lung cancer metastatic, pulmonary haemorrhage on Jul 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 61 years of age, . Clexane dosage: . During the same period patient was treated with DALTEPARIN SODIUM (View Dalteparin Sodium Review and Dalteparin Sodium Label ), CODEINE LINCTUS (View Codeine Linctus Review and Codeine Linctus Label ), IBUPROFEN TABLETS (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ). Patient was hospitalized.

6856068-6 | Epistaxis, International Normalised Ratio Increased
Adverse event was reported on Jul 08, 2010 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: ITALY , 82 years of age, After Clexane was administered, patient had the following side effects: epistaxis, international normalised ratio increased. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (View Tramadol Hydrochloride And Acetaminophen Review and Tramadol Hydrochloride And Acetaminophen Label ).

6847816-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Enzyme Increased, Hepatic Function Abnormal
on Jul 01, 2010 Female patient from JAPAN , 60 years of age, weighting 117.3 lb, was diagnosed with abdominal operation, procedural pain, postoperative care and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic enzyme increased, hepatic function abnormal. Clexane dosage: . During the same period patient was treated with AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), LOXONIN (View Loxonin Review and Loxonin Label ), SELBEX (View Selbex Review and Selbex Label ), CEFMETAZON (View Cefmetazon Review and Cefmetazon Label ). Patient was hospitalized.

6847790-6 | Hepatocellular Injury, Pancreatic Enzymes Increased
on Jul 01, 2010 Male patient from SWITZERLAND , 23 years of age, was treated with Clexane (View Usage). Patient had the following side effects: hepatocellular injury, pancreatic enzymes increased. Clexane dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), TAZOBAC (View Tazobac Review and Tazobac Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), TORADOL (View Toradol Review and Toradol Label ).

6847782-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Hepatic Function Abnormal
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal on Jul 01, 2010 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 145.5 lb, was diagnosed with abdominal operation and. Clexane dosage: . During the same period patient was treated with NSAID'S (View Nsaid's Review and Nsaid's Label ), CEFMETAZON (View Cefmetazon Review and Cefmetazon Label ), DAIKENTYUTO (View Daikentyuto Review and Daikentyuto Label ), LOXONIN (View Loxonin Review and Loxonin Label ), SELBEX (View Selbex Review and Selbex Label ), PANTOL (View Pantol Review and Pantol Label ), VEEN D (View Veen D Review and Veen D Label ). Patient was hospitalized.

6836505-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Jaundice, Transaminases Increased
Adverse event was reported on Apr 29, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with immobile and. Location: GERMANY , 78 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, jaundice (What is jaundice?), transaminases increased. During the same period patient was treated with FLUPIRTINE MALEATE (View Flupirtine Maleate Review and Flupirtine Maleate Label ), METAMIZOLE (Daily Dose: 4 Df Dosage Form Every Days) (View Metamizole Review and Metamizole Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6836502-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
on Jul 01, 2010 Female patient from JAPAN , 69 years of age, weighting 133.4 lb, was diagnosed with abdominal operation and was treated with Clexane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Clexane dosage: . During the same period patient was treated with TENORMIN (View Tenormin Review and Tenormin Label ), AMLODIN (View Amlodin Review and Amlodin Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), HALCION (View Halcion Review and Halcion Label ), HERBAL PREPARATION (View Herbal Preparation Review and Herbal Preparation Label ), ANTITHROMBOTIC AGENTS (View Antithrombotic Agents Review and Antithrombotic Agents Label ). Patient was hospitalized.

6814288-0 | Hypoaesthesia
on Jun 01, 2010 Female patient from JAPAN , 55 years of age, weighting 160.9 lb, was diagnosed with infection prophylaxis and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: hypoaesthesia. Clexane dosage: . During the same period patient was treated with CEFMETAZON (View Cefmetazon Review and Cefmetazon Label ), FLOMOX (View Flomox Review and Flomox Label ).

6779429-2 | Cerebrovascular Accident
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident on Jun 15, 2010 from GERMANY Additional patient health information: Male patient , 74 years of age, weighting 165.3 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Clexane dosage: Daily Dose: 80 Mg Millgram(s) Every Days.

6779275-X | Liver Injury
Adverse event was reported on Apr 23, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: GERMANY , 22 years of age, weighting 125.7 lb, Patient had the following side effects: liver injury. During the same period patient was treated with PANTOZOL (View Pantozol Review and Pantozol Label ), OXYGESIC (View Oxygesic Review and Oxygesic Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), BERLOSIN (View Berlosin Review and Berlosin Label ). Patient was hospitalized.

6771371-6 | Scotoma
on Jun 07, 2010 Male patient from UNITED KINGDOM , 78 years of age, was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: scotoma. Clexane dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6727435-6 | Thrombosis In Device
on May 12, 2010 Male patient from COLOMBIA , 52 years of age, was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis in device. Clexane dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6727307-7 | Hepatic Function Abnormal
Patient was taking Clexane (View Usage). Patient had the following side effects: hepatic function abnormal on May 12, 2010 from JAPAN Additional patient health information: Female patient , 58 years of age, weighting 127.9 lb, was diagnosed with anaemia, inflammation, gastritis and. Clexane dosage: . During the same period patient was treated with PANSPORIN (View Pansporin Review and Pansporin Label ), MEIACT (Dose As Used: 2a) (View Meiact Review and Meiact Label ), FERROMIA (View Ferromia Review and Ferromia Label ), IRZAIM (View Irzaim Review and Irzaim Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), LOXONIN (View Loxonin Review and Loxonin Label ).

6713041-6 | In-stent Coronary Artery Restenosis
Adverse event was reported on Apr 29, 2010 by a Male patient taking Clexane (View Usage) (Dosage: ) was diagnosed with acute coronary syndrome and. Location: COLOMBIA , 47 years of age, After Clexane was administered, patient had the following side effects: in-stent coronary artery restenosis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6711314-4 | In-stent Coronary Artery Restenosis
on Apr 29, 2010 Female patient from COLOMBIA , 73 years of age, was diagnosed with acute coronary syndrome and was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: in-stent coronary artery restenosis. Clexane dosage: 40mg And 60mg. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6703696-4 | Jaundice, Transaminases Increased
on Apr 29, 2010 Female patient from GERMANY , 78 years of age, weighting 158.7 lb, was treated with Clexane (View Usage). Patient had the following side effects: jaundice (What is jaundice?), transaminases increased. Clexane dosage: . During the same period patient was treated with FLUPIRTINE MALEATE (View Flupirtine Maleate Review and Flupirtine Maleate Label ), METAMIZOLE (Daily Dose: 4 Df Dosage Form Every Days) (View Metamizole Review and Metamizole Label ). Patient was hospitalized.

6700135-4 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Apathy, Blood Alkaline Phosphatase Increased, Blood Cholesterol Increased, Decreased Appetite, Dysgeusia, Gamma-glutamyltransferase Increased, Hepatotoxicity
Patient was taking Clexane (View Usage). After Clexane was administered, patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, apathy, blood alkaline phosphatase increased, blood cholesterol increased, decreased appetite, dysgeusia, gamma-glutamyltransferase increased, hepatotoxicity on Feb 26, 2010 from GERMANY Additional patient health information: Female patient , 66 years of age, weighting 143.3 lb, was diagnosed with thrombosis prophylaxis, urinary tract infection (What is urinary tract infection?) and. Clexane dosage: . During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ).

6696659-9 | Liver Injury
Adverse event was reported on Apr 23, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: GERMANY , 22 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: liver injury. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), OXYGESIC (View Oxygesic Review and Oxygesic Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), BERLOSIN (View Berlosin Review and Berlosin Label ). Patient was hospitalized.

6644240-X | Hepatic Function Abnormal
on Mar 17, 2010 Female patient from JAPAN , 73 years of age, weighting 83.78 lb, was diagnosed with cholelithotomy, infection prophylaxis and was treated with Clexane (View Usage). Patient had the following side effects: hepatic function abnormal. Clexane dosage: . During the same period patient was treated with TANATRIL ^TANABE^ (View Tanatril ^tanabe^ Review and Tanatril ^tanabe^ Label ), EVISTA (View Evista Review and Evista Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), LOXOPROFEN (View Loxoprofen Review and Loxoprofen Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), AMPICILLIN SODIUM/SULBACTAM SODIUM (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ). Patient was hospitalized.

6642344-9 | Spinal Haematoma
on Mar 18, 2010 Female patient from GERMANY , 70 years of age, weighting 108.0 lb, was diagnosed with thrombosis prophylaxis and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: spinal haematoma. Clexane dosage: .

6637993-8 | Hallucination
Patient was taking Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination on Mar 12, 2010 from AUSTRALIA Additional patient health information: Male patient , 65 years of age, . Clexane dosage: . During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ).

6628379-0 | Deep Vein Thrombosis
Adverse event was reported on Mar 10, 2010 by a Female patient taking Clexane (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis, contraception and. Location: GERMANY , 24 years of age, weighting 198.4 lb, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). During the same period patient was treated with ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ).

6617999-5 | Deep Vein Thrombosis
on Mar 03, 2010 Female patient from GERMANY , weighting 198.4 lb, was diagnosed with thrombosis prophylaxis, contraception and was treated with Clexane (View Usage). After Clexane was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Clexane dosage: . During the same period patient was treated with ORAL CONTRACEPTIVE NOS (View Oral Contraceptive Nos Review and Oral Contraceptive Nos Label ).

6613510-3 | Leukopenia, Pyrexia, Thrombocytopenia
on Feb 25, 2010 Male patient from SWITZERLAND , 78 years of age, weighting 132.3 lb, was treated with Clexane (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, pyrexia, thrombocytopenia. Clexane dosage: . During the same period patient was treated with ALDARA (5 Per 7 Days) (View Aldara Review and Aldara Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COSAAR PLUS (View Cosaar Plus Review and Cosaar Plus Label ), CALCIMAGON D3 (View Calcimagon-d3 Review and Calcimagon-d3 Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ). Patient was hospitalized.

6613505-X | Postoperative Wound Infection
Patient was taking Clexane (View Usage). Patient had the following side effects: postoperative wound infection on Feb 26, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, weighting 132.3 lb, . Clexane dosage: . During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), OMEPRAL (View Omepral Review and Omepral Label ), CLOSTRIDIUM BUTYRICUM (View Clostridium Butyricum Review and Clostridium Butyricum Label ), BIOTIN (View Biotin Review and Biotin Label ), CINAL (View Cinal Review and Cinal Label ), FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ). Patient was hospitalized.